Opioid drugmakers face thousands of lawsuits around the country, a mountain of them grouped in Cleveland’s federal court. But right now, it's a Monday decision—in the first opioid case to make it to trial nationally—that has market watchers bracing for news.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,